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The richness of niche-ness – an introduction
Arthur D Lander
Ideas about stem cells, and how they behave, have been 
undergoing  a  lot  of  change  in  recent  years,  thanks  to 
developments in visualizing, monitoring, and manipulating 
cells and tissues. Curious to find out what impact these 
changes  are  having  on  one  of  the  most  enduring  and 
widely accepted metaphors in stem cell biology – the idea 
of the stem cell niche – BMC Biology asked researchers 
working  on  a  variety  of  systems  to  write  about  their 
current conception of what a stem cell niche really is.
The answers presented below suggest that the detailed 
mechanisms  underlying  niche  function  are  extremely 
varied. Niches may be composed of cells, or cells together 
with  extracellular  structures  such  as  the  extracellular 
matrix (ECM). They may be sources of secreted or cell 
surface factors – including members of the Notch, Wnt, 
fibroblast growth factor (FGF), epidermal growth factor 
(EGF),  transforming  growth  factor  (TGF)-β,  stem  cell 
factor (SCF), and chemokine families – that control stem 
cell renewal, maintenance, or survival. They may consist 
of just a single cell type, or a whole host of interacting 
cells. They may derive from cells outside the stem cell’s 
lineage, or they may derive primarily from the stem cell’s 
own  descendents.  In  general,  there  seems  to  be  much 
more consensus about the fact that stem cells invariably 
need  niches  than  about  the  specific  mechanisms  by 
which niches do their jobs.
Why should a stem cell need a special environment? 
This  is  a  pertinent  question,  given  that  none  of  the 
elementary processes that stem cells rely upon – growing, 
dividing, differentiating – are unique to stem cells. We 
can easily imagine three classes of answers:
One  possibility  is  that  there  are  demands  placed  on 
stem cells that necessitate special support for viability. 
For example, the need, imposed by cellular immortality, 
to minimize the accumulation of genetic damage, may 
drive stem cells to adopt a peculiar metabolic state that 
might  force  them  to  rely  upon  other  cells  nearby  for 
sustenance. This ‘nutritive’ function of the niche remains 
a formal possibility, but in most systems few experimental 
data in support of it have so far emerged.
A  second  possibility  is  that  niches  are  agents  of 
feedback  control.  Recent  studies  tell  us  that  stem  cell 
pools are not slavishly maintained at a constant size by 
fixed,  asymmetric  divisions,  but  are  usually  capable  of 
expanding or contracting and, even under homeostatic 
conditions,  may  face  large  stochastic  fluctuations.  The 
varied  growth  factors  and  cell  surface  molecules 
produced by niche cells may share the common goal of 
controlling stem cell pools. If this is the case, then the 
niche  might  best  be  thought  of  not  simply  as  an 
environment conducive to stem cell functioning, but as 
an apparatus for communicating information about the 
state of a tissue back to the stem cells that maintain it. An 
important question to address would then be how niches 
obtain and relay such information.
A  third  possibility  is  that  niches  are  instruments  of 
coordination among tissue compartments. Some of the 
best evidence for this view comes from work on the hair 
follicle  niche,  described  below  by  Elaine  Fuchs.  There, 
stem and progenitor cells responsible for maintenance of 
epidermis,  pigmentation,  hair,  and  connective  and 
adipose tissue all interact in close proximity. A need to 
achieve  tight  coordination  among  these  different  cell 
populations may be the overriding reason for complex 
organization  of  this  niche.  The  possibility  that  other 
niches may also be hubs of inter-lineage coordination is 
certainly an idea worth investigating.
The C. elegans distal tip cell and the concept of 
a stem cell niche
Judith Kimble
Schofield  originally  hypothesized  the  existence  of  a 
microenvironment required for maintenance of stem cells 
and coined the term stem cell niche [1] (Figure 1a, left). 
The  first  example  of  such  a  stem  cell  niche  was  the 
mesenchymal  ‘distal  tip  cell’  (DTC)  in  Caenorhabditis 
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DTC provides the essential microenvironment, or ‘niche’ , 
for maintenance of germline stem cells (GSCs; Figure 1b). 
The  DTC  is  required  during  development  for  GSCs  to 
generate  the  adult  germline  tissue  [2],  and  in  adults  to 
maintain it [3,4]. Both during development and in adults, 
GSCs are maintained by proximity to the DTC rather than 
by  asymmetric  cell  division  [2-4].  In  adults,  the  DTC 
extends  processes  to  embrace  a  pool  of  GSCs  with 
equivalent potential [3,5], a pool that can regenerate a fully 
functional  germline  tissue  [6,7].  The  simplicity  of  this 
niche together with its existence in a genetically tractable 
organism has made it a paradigm for stem cell control.
The molecular circuitry underlying DTC regulation of 
GSC  maintenance  provides  the  basis  for  a  molecular 
definition of the niche. Briefly, the DTC uses a signaling 
pathway  that  is  broadly  conserved  among  metazoans, 
known as Notch signaling, to regulate GSC maintenance; 
GSCs  respond  to  Notch  signaling  via  an  elaborate 
network of mRNA and cell cycle regulators (Figure 1c) 
[8,9]. A major hub of this network is FBF, which is crucial 
for GSC self-renewal; FBF is a sequence-specific PUF (for 
Pumilio  and  FBF)  RNA-binding  protein  and  broad-
spectrum repressor of differentiation (for example, [10-
12]). This FBF hub may reflect the existence of either a 
fundamental mechanism that acts in many types of stem 
cells or a specialized mechanism that acts primarily in 
GSCs  to  protect  their  totipotency.  A  signature  of  this 
network  is  a  pervasive  redundancy  that  made  the 
circuitry  challenging  to  unravel  experimentally,  but 
renders GSC decisions (self-renewal versus differentiation) 
highly robust and regulatable [9,10]. So how is the niche 
defined in molecular terms? A minimalist view is that the 
DTC  membrane  presenting  Notch  ligands  to  adjacent 
GSCs defines the niche (Figure 1c, dark red). A broader 
view includes the DTC itself as integral to the continuous 
Notch signaling at its surface (Figure 1c, pink).
Investigations  of  the  DTC  and  Notch  signaling  have 
expanded our notion of what a stem cell niche can do. 
Normally germ cells mature in a gradient, with GSCs at 
the distal end, differentiated gametes at the proximal end 
and  progressively  maturing  germ  cells  in  between 
(Figure 1d). The DTC and Notch signaling establish and 
maintain  that  pattern  of  maturation  [2,13],  and  also 
regulate formation of normal oocytes at the proximal end 
of the tissue [14]. Therefore, the influence of the niche 
extends  beyond  stem  cell  control  to  include  the 
regulation of tissue organization and function.
Investigations  of  the  DTC  and  Notch  signaling  also 
provide insights into the developmental generation of a 
niche,  a  process  essential  for  stem  cell  regulation.  The 
DTC arises from an asymmetric cell division [15], and 
the  Wnt  signaling  pathway  and  CEH-22/Nkx2.5 
transcription factor specify its niche properties [16,17]. 
Manipulation of the Wnt pathway and CEH-22 can direct 
formation of ectopic niches, ectopic GSCs and ectopic 
maturation gradients [16,17]. In addition, a ‘latent niche’ 
was revealed when immature germ cells aberrantly came 
into  contact  with  non-DTC  cells  expressing  Notch 
ligands  (Figure  1d)  [18].  Such  a  latent  niche  drives 
formation  of  a  germline  tumor,  perhaps  because  its 
geometry interferes with the movement of GSC progeny 
out of the niche.
The intestinal crypt niche
Hans Clevers
A minimal definition of an adult stem cell involves only 
two criteria: 1) an adult stem cell persists for the lifetime 
of the animal (‘longevity’); and 2) an adult stem cell can 
Figure 1. The Caenorhabditis elegans distal tip cell (DTC) and 
the concept of a stem cell niche. (a) Left, the stem cell niche 
hypothesis from Schofield [1]; right, the C. elegans DTC (red) provides 
the stem cell niche for the germline stem cell (GSC) pool (yellow). 
(b) Images of the adult DTC and its processes. Left, cytoplasmic 
green fluorescent protein (green) highlights the DTC and its 
processes that embrace GSCs. Blue, germline nuclei; red, germline 
membranes. Modified from [10]. Middle, electron microscopy (EM) 
image of DTC and its processes. Modified from [10]. Right, scanning 
EM image of distal gonad; image courtesy of David Greenstein [19]. 
An asterisk (*) marks one GSC in each image; arrowheads mark 
processes. (c) Molecular view of the niche and its control of GSC 
self-renewal or differentiation. Dark red, minimalist view of niche as 
the surface presenting Notch ligands; pink, broader view of niche 
including DTC as integral to providing the microenvironment for 
GSC control. (d) Expansion of niche concept based on investigations 
of DTC and Notch signaling in C. elegans. See text for explanation.
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Page 2 of 15make  all  cell  types  of  the  tissue  to  which  it  belongs 
(‘multipotency’). Adult stem cells typically depend on a 
close interaction with a dedicated cellular environment, 
the so-called niche. While it has been possible to study 
invertebrate stem cells and their niches with single-cell 
resolution, the size of mammalian tissues combined with 
the infrequent occurrence of stem cells have complicated 
the identification of individual stem cells in vivo [20]. The 
epithelium of the mammalian small intestine presents a 
prototypic  example  of  the  hierarchical  organization  of 
stem cell-driven, self-renewing tissues. A limited number 
of stem cells reside at the crypt base. Each of these stem 
cells divides once per day [21]. Daughter cells can exit the 
stem cell compartment into the transit amplifying (TA) 
compartment.  TA  cells  undergo  approximately  four  to 
five rounds of division approximately every 12 hours, an 
unusually short duration [21]. TA cells differentiate into 
differentiated cell types, such as enterocytes, goblet cells 
and enteroendocrine cells, which continue to move up 
the flanks of the villi. Upon reaching the villus tip after 
two to three more days, the differentiated cells undergo 
apoptosis. A fourth cell type, the Paneth cell, also derives 
from the stem cells, but migrates downwards and settles 
at the crypt base to live for four to six weeks [22].
Two competing schools of thought have existed as to 
the identity of the crypt stem cell before lineage-tracing 
approaches  were  developed.  Leblond  and  colleagues 
originally proposed small cycling cells located between 
the Paneth cells, the crypt base columnar cells [23,24] as 
stem cells. Potten proposed the first non-differentiated 
cell directly above the Paneth cells – the +4 cell – as stem 
cells.  Of  note,  Potten  showed  that  these  cells  are  not 
quiescent but cycle every 24 hours [21]. It was recently 
found  that  Leblond’s  crypt  base  columnar  cells 
specifically express the Lgr5 gene, encoding the leucine-
rich repeat-containing G-protein coupled receptor 5 [25] 
(Figure 2). Lineage tracing demonstrated that the Lgr5hi 
cells  generate  all  cell  types  of  the  small  intestinal 
epithelium over the lifetime of the animal, thus fulfilling 
the  above  criteria.  Similar  data  were  obtained  using  a 
CD133-based  lineage-tracing  strategy  [26].  As  further 
proof of ‘stemness’, a single Lgr5hi cell can grow in vitro as 
an ever-expanding epithelial organoid, or mini-gut, that 
shows all the hallmarks of the in vivo epithelial tissue, 
unveiling  an  unusual  level  of  architectural  self-
organization in the absence of a niche consisting of non-
epithelial cells [27].
Lgr5 stem cells are closely associated with Paneth cells 
in vivo and in vitro. Paneth cells are known to produce 
bactericidal products, but they also make EGF, TGF-α, 
Wnt3  and  the  Notch  ligand  Dll4,  the  essential 
components of the mini-gut culture system [27]. While 
single sorted stem cells grow inefficiently in culture, stem 
cell/Paneth cell doublets robustly generate mini-guts. In 
vivo,  genetic  removal  of  Paneth  cells  results  in  the 
concomitant loss of Lgr5 stem cells. Thus, Paneth cells, 
daughters of Lgr5 stem cells, provide essential stem cell 
niche signals.
Each crypt contains around 15 stem cells and 15 Paneth 
cells. As a population, Lgr5 stem cells persist life-long, 
yet crypts drift towards clonality within a period of one 
to six months (Figure 3). We have collected short and 
Figure 2. Expression of Lgr5-GFP at crypt bottoms. (a) Lgrf-5 is shown in green, with a counterstain for DNA in red to outline crypts and villi. 
(b) Lgr5 marks cycling crypt base columnar cells. Lgr5 expression appears in brown, in between the white/blue Paneth cells at crypt bottoms. 
(c) Schematic of crypt architecture. Reproduced, with permission from Elsevier, from Barker N, Clevers H: Gastroenterology 2007, 133:1755-1760.
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The combined data do not support asymmetric stem cell 
division. Rather, each crypt appears to provide space for a 
fixed number of Lgr5hi stem cells. Each day, the resident 
stem cells double their numbers by symmetric divisions, 
after which they stochastically adopt stem or TA fates as 
the outcome of competition for available niche space – 
the  available  Paneth  cell  surface.  This  determines  the 
number  of  Lgr5hi  stem  cells  in  a  crypt.  Paneth  cell 
numbers are therefore the key determinant of the stem 
cell niche and must be tightly regulated under normal 
homeostatic conditions, which is indeed the case [28]. It 
will be of interest to understand what determines Paneth 
cell numbers and their slow turnover rate.
The hair follicle stem cell niche
Elaine Fuchs
Stem  cells  reside  in  specialized  microenvironments, 
known as ‘niches’ [29]. Cellular components of the niche 
participate importantly in governing stem cell behaviors, 
ranging from dormancy and activation to migration and 
differentiation.  Until  recently,  the  niche  components 
impacting  on  stemness  were  assumed  to  derive  from 
heterologous  cell  types  of  non-stem  cell  lineages. 
Unexpectedly,  however,  increasing  evidence  from  both 
invertebrates and vertebrates has begun to broaden this 
view  to  include  stem  cell  progeny  themselves  as 
important  niche  components  that  regulate  stem  cell 
activity and behavior.
Figure 3. Stem cells are marked in individual colors by the multicolor Cre reporter Confetti. (a) Each crypt becomes monochromatic 
over time (bottom of image), producing parallel bands of differently colored cells on villus flanks. (b) Confocal sectioning through multiple 
crypt bottoms. When individual stem cells are marked with different Confetti colors, crypts resolve to monoclonality (that is, they become 
monochromatic in 4 to 8 weeks due to neutral competition of the stem cells). All images in this figure were reproduced with permission from 
Elsevier, from Snippert H et al.: Cell 2010, 143:134-144.
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Page 4 of 15The skin is the largest organ, and its enormous need for 
tissue regeneration makes it the most abundant source of 
stem cells of our body. Hair follicles of the skin are unique 
in  that  they  undergo  synchronized,  cyclical  bouts  of 
tissue regeneration beginning with a phase in which the 
hair grows out, followed by a destructive phase in which 
the hair stops growing and the lower two-thirds of the 
follicle degenerates. The destructive phase is followed by 
a period of rest, after which the cycle begins anew. As 
such, the hair follicle stem cells, which fuel this tissue 
regeneration, undergo extended periods of rest, and are 
only briefly activated at the beginning of each hair cycle 
[30]. Given the beauty of this system, the hair follicle has 
emerged as an important paradigm to study stem cells in 
quiescence and in action.
Hair follicle stem cells reside in the outermost layer of 
the ‘bulge’, an anatomical region located just below the 
sebaceous glands of the follicles [31,32] (Figure 4a). The 
bulge niche hosts not only hair follicle stem cells, but also 
melanocyte  stem  cells,  the  latter  interspersed  between 
the former [33,34]. The behaviors of these two stem cell 
populations are well-coordinated, enabling differentiating 
melanocytes  to  generate  and  transfer  pigment  to  the 
transiently  amplifying,  committed  hair  follicle 
progenitors as they begin to terminally differentiate to 
produce hair shaft cells. The niche is also surrounded by 
a basement membrane of ECM, a dermal sheath, and a 
variety of sensory neurons and blood vessels. Just above 
the  bulge  is  the  arrector  pili  muscle  –  responsible  for 
making hairs stand up – which places its mesenchymal 
stem cells at the crossroads [35]. As such, the bulge niche 
is a complex but rich milieu of inputs.
An unusual feature of the hair follicle stem cell niche is 
that one of its key stimulatory components is transient. 
The  dermal  papilla  is  a  cluster  of  specialized 
mesenchymal cells that rests adjacent to the bulge niche 
during  the  resting  phase  of  the  hair  cycle,  but  moves 
downward with the committed proliferative progenitors 
following  transition  to  the  growing  phase.  During  the 
dormant phase, crosstalk between the dermal papilla and 
the hair follicle stem cells contributes to the threshold of 
activating  cues  (Wnts,  bone  morphogenetic  protein 
(BMP) inhibitors and TGF-βs) necessary to shift the stem 
cells from a quiescent to an activated state [36-45].
Figure 4. Homeostasis and repair of the adult tissues depends on tissue-specific stem cells. (a) The architecture of the hair follicle stem cell 
niche. The hair follicle stem cells are marked by CD34 staining (in green). One of their important niche components is the inner layer of the bulge, 
marked by K6 staining (in red) and composed of differentiated hair follicle stem cell progeny that underwent the transition from slow-cycling 
to faster-cycling. This feature was exploited by bromodeoxyuridine (BrdU) nucleotide pulse-chase to mark the inner layer cells with blue BrdU 
staining in the figure. This inner layer of bulge cells plays a key role in maintaining the quiescence of the outer layer of hair follicle stem cells. This 
image is courtesy of Y-C Hsu and E Fuchs. (b) The hair follicle stem cells are marked by CD34 staining (in green) and are quiescent, due to the high 
level of bone morphogenetic protein (BMP) signaling within the niche, as shown here by the nuclear staining for phosphorylated Smad1 (in red), 
the transcriptional effector of the BMP pathway. The nuclei of the skin cells are marked here in Keratin-5 (blue), which reveals the presence of the 
emerging hair follicle below the activated stem cell niche. This is a classical sign of entry into the growth phase of the new hair cycle. This image is 
courtesy of N Oshimori and E Fuchs.
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Page 5 of 15Another facet of the hair follicle involves the molecular 
brakes  that  put  its  stem  cells  back  into  quiescence 
following an active period of tissue regeneration. In the 
past year, it was discovered that as hair follicle stem cells 
progress along their lineages and near completion of the 
active production of the hair and its channel, some of the 
terminally  differentiated  progeny  midstream  along  the 
lineage wind up back in the bulge. There, they reside in 
the  inner  layer  that  is  sandwiched  between  the  outer 
layer of hair follicle stem cells and the inner core that 
contains the hair shaft. These invading progeny have lost 
their  potential  for  stemness  and  do  not  regain  it  even 
upon wounding. However, they contribute heavily to the 
niche by transmitting potent BMP and FGF signals that 
maintain stem cells in a quiescent state [46] (Figure 4b). 
To reactivate the hair cycle, activating cues must overcome 
the  inhibitory  inputs.  Compounding  these  localized 
niche signals, the balance is also influenced by waves of 
macro-environmental signals emanating from the dermal 
adipose tissue [47-49]. These long-range signals help to 
synchronize the stem cell niches in the hair coat.
Overall, the ease of working with the hair follicle stem 
cell  niche,  the  abundance  of  its  stem  cells,  and  the 
synchronized bouts of natural tissue regeneration have 
catapulted this system to a prominent position in niche 
research.  The  complexity  of  its  niche  signals  and  the 
diversity of stem cells within this niche will keep the field 
occupied for the decade to come.
Skeletal muscle: the satellite cell niche
Didier Montarras and Margaret Buckingham
The repair of adult skeletal muscle depends on muscle 
satellite  cells,  which,  when  activated  upon  injury,  will 
proliferate  and  then  differentiate  to  make  new  muscle 
fibers, or, after self-renewal, re-constitute the reserve of 
muscle progenitors. The satellite cell therefore displays 
properties of a tissue-specific stem cell [50]. In normal 
adult  muscle,  it  is  localized  as  a  ‘satellite’  in  close 
association with the muscle fiber [51], under the basal 
lamina,  which  separates  individual  fibers  from  the 
interstitial  space.  This  is  the  niche  of  the  quiescent 
satellite cell. There is as yet no clear evidence that the 
fiber itself regulates the positioning of the satellite cell. 
Myonuclei  lie  on  the  periphery  of  the  contractile 
apparatus, which occupies the central core of the fiber, 
although they are spaced along the fiber without obvious 
synchronization in relation to satellite cells. The fiber is 
contacted  by  tendons  and  nerves  and  it  has  been 
proposed that there is a relationship between myoneural 
junctions and satellite cell density [52], but this requires 
further  investigation.  The  interstitial  space  is  mainly 
occupied by a heterogeneous population of connective 
tissue cells and blood vessels and there is accumulating 
evidence that vascularization influences the satellite cell 
niche [53]. A remarkable feature of skeletal muscle is that 
the number of satellite cells per fiber does not vary for a 
given  fiber  type  and  is  precisely  reconstituted  after 
regeneration.  Between  fiber  types  this  fixed  number  is 
different,  with  a  four-fold  increase  in  satellite  cells  for 
slow oxidative (‘slow twitch’) compared to fast glycolytic 
(‘fast  twitch’)  fibers.  This  phenomenon  correlates  with 
the  denser  network  of  blood  vessels  in  slow  oxidative 
muscles  and  more  recent  investigations  have 
demonstrated that satellite cells are frequently found in 
the  vicinity  of  blood  vessels.  There  is  evidence  for 
crosstalk between satellite cells expressing the receptor 
Tie2  and  neighboring  capillary  associated  cells  (for 
example,  pericytes)  producing  Angiopoietin1,  which 
contributes to the maintenance of quiescence. The Notch 
pathway has also now been implicated in the maintenance 
of  quiescence.  If  Notch  signaling  is  disrupted,  satellite 
cells  spontaneously  activate  and  differentiate  in  the 
absence of injury. Surprisingly, this takes place without 
proliferation, leading to depletion of satellite cells, so that 
regeneration  is  impaired  [54,55].  Satellite  cells  express 
the Notch receptor, but the source of the ligand required 
to  activate  the  pathway  is  not  yet  clear.  However,  the 
muscle fiber is probably the best candidate, since it is in 
direct contact with the satellite cell and Notch ligands are 
transmembrane  proteins.  Furthermore,  there  is 
experimental  evidence  for  production  of  the  Notch 
ligand Delta by the fiber [56].
The  satellite  cell  is  anchored  to  the  surface  of  the 
muscle fiber and to the basal lamina, as exemplified by 
M-cadherin and integrin/laminin interactions, respectively. 
The notion that the satellite cell actively participates in 
the  building  of  an  environment  that  maintains 
quiescence, but allows it to remain poised for activation, 
is illustrated by in vivo expression profiling studies [57]. 
Quiescent satellite cells are marked by the expression of 
genes for secreted inhibitors of proteases (Serpin, Tfpi2) 
and also for tissue inhibitors of metalloproteases, such as 
Timp4,  whereas  on  activation,  when  the  satellite  cell 
breaks  away  from  its  niche,  these  are  rapidly  down-
regulated, and the satellite cell produces high levels of 
proteases.  Transcripts  of  proteins  associated  with  cell 
motility, such as Doublecortin, are also up-regulated on 
activation. The satellite cell also modulates the activity of 
signaling molecules, such as FGF, by secreting enzymes 
involved in de-sulfation that modify proteoglycans in the 
ECM  [58]  or  growth  factor  binding  proteins  such  as 
Igfbp6. In addition to modulating its environment, like 
other long-lived quiescent stem cells, the satellite cell is 
also  well  armed  against  genotoxic  substances  and 
oxidative stress. Thus, the satellite cell of skeletal muscle 
in its niche on the fiber is subject to signaling from its 
surroundings (Figure 5) and is also actively involved in 
maintaining its quiescent state.
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Page 6 of 15Building one’s own nest – what the olfactory 
epithelium suggests about neuronal stem cell niches
Anne L Calof
Since  the  central  nervous  system  (CNS)  does  not 
regenerate to any significant extent, at least in mammals, 
it  was  long  assumed  that  the  CNS  lacks  stem  cells 
(rendering any questions about neuronal stem cell niches 
moot).  In  the  1960s,  however,  investigators  such  as 
Joseph Altman and colleagues, using the new technique 
of  injecting  3H-thymidine  to  label  cells  in  S  phase, 
obtained evidence that some CNS glial cells – and a few 
cells that were apparently neurons (generally defined as 
being post-mitotic, terminally differentiated cells) – were 
the progeny of progenitor cells still functioning (dividing) 
in postnatal rodents [59-61].These progenitor cells were 
found  in  the  regions  near  the  lateral  ventricles  of  the 
forebrain (the subventricular zone, or SVZ) and a part of 
the dentate gyrus of the hippocampus now often referred 
to, by analogy, as the subgranular zone (SGZ).
Now, five decades later, hundreds of articles have been 
devoted to the study of neuronal stem cells in these two 
regions (the SVZ and the SGZ), which still appear to be 
the only consistent sites of sustained neurogenesis and 
neuronal  regeneration  in  the  mammalian  CNS.  As  a 
result,  a  lot  is  being  learned  about  the  nature  of  the 
‘niches’  that  support  proliferation,  self-renewal,  and 
differentiation of stem cells into neurons and glia in these 
regions of the brain [62-64]. As one might expect, most 
signaling molecule families that are important in neural 
development  (EGFs,  TGF-ßs,  FGFs,  Notch,  Shh,  and 
others) are also important in the maintenance of stem 
cells in the adult brain, and can be found in or around 
these niches [65-67]. It is not surprising, and certainly 
significant,  that  regions  of  the  brain  that  retain 
characteristics of the embryonic environment in which 
the brain was generated are crucial for the maintenance 
of  stem  cells  that  retain  the  capacity  for  generating 
neurons. Another very interesting aspect of these CNS 
niches is that they are invariably juxtaposed to supporting 
cell  tissues:  they  are  found  near  blood  vessels,  the 
ventricles  that  line  the  brain  (and  hence  near  both 
ependymal  cells  and  the  cerebrospinal  fluid  these  cells 
produce), or both [68].
Such  juxtapostion  of  neuronal  stem  cells  with  non-
neural supporting cell tissue is characteristic of a part of 
the  peripheral  nervous  system  that  is  famous  for  its 
ability  to  maintain  lifelong  neurogenesis:  the  olfactory 
epithelium (OE). The OE generates – and regenerates – 
olfactory receptor neurons (ORNs) throughout life from 
stem  cells  that  lie  in  the  basal  compartment  of  the 
epithelium; and it does so robustly in response to injury 
(for example, [69] and references therein). Importantly, 
Figure 5. A representation (not to scale) of the satellite cell, marked by Pax7, in its niche on the muscle fiber under the basal lamina in 
proximity to a blood vessel. Cell adhesion molecules, signals received from surrounding tissues, and molecules secreted by the satellite cell that 
regulate the niche and promote the quiescent state, discussed in the text, are illustrated. IGF, insulin-like growth factor; M CADH, M-cadherin.
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similarities to the neuroepithelial primordia that generate 
the  rest  of  the  nervous  system,  including  its  epithelial 
structure  and  its  dependence  on  a  subjacent  stroma 
derived from mesenchyme and neural crest [70,71]. This 
stroma  is  required  for  the  maintenance  of  stem  cell 
activity, since survival of isolated OE neural stem cells at 
low density is only possible when they are cultured on 
stromal feeder cells [72].
Given  that  the  OE’s  neurogenic  capacity  appears  far 
greater than that of the SVZ or SGZ, the OE presents us 
with  an  opportunity  to  identify  basic  principles 
underlying the organization of neuronal stem cell niches. 
Interestingly, recent studies suggest that the stem cells of 
the OE play a major role in building their own niche. In 
particular, the proliferation and self-renewal of OE stem 
cells appears to be under the control of a host of diffusible 
factors produced by stem cells, their progeny and their 
neighbors. For example, OE stem cells and their progeny 
make  morphogens  such  as  GDF11  and  activin,  which 
feed  back  to  inhibit  stem  cell  proliferation  and  self-
renewal,  providing  a  mechanism  for  control  of  cell 
number [73-75]. The mesenchymal cells of the stroma, in 
contrast,  make  GDF7,  which  stimulates  neurogenesis 
([71],  and  unpublished  observations)  and  follistatin  (a 
secreted molecule that irreversibly inhibits both GDF11 
and  activin).  Given  the  expected  range  of  diffusion  of 
these sorts of molecules (on the scale of 10 to 100 µm), it 
quickly  becomes  apparent  that  the  environment  most 
conducive to stem cell maintenance should exist at the 
interface  between  epithelium  and  stroma  (Figure  6),  a 
result that is supported by mathematical modeling [76]. 
Indeed,  as  decades  of  study  have  shown,  the  basal 
compartment of the OE is precisely where its neuronal 
stem cells reside.
It  appears,  then,  that  OE  neural  stem  cells,  together 
with  their  neighbors,  assemble  their  own  niche.  The 
question for the future is whether the same is true for 
those  areas  of  the  CNS  that  have  the  capacity  to 
regenerate. Thus, it should be fruitful to take a closer look 
at SVZ and SGZ development, focusing in particular on 
how  development  initially  constructs  the  cellular 
neighborhood in which the stem cells of these mature 
structures come to reside.
Hematopoietic stem cell-niche units in the bone 
marrow
Andreas Trumpp
Hematopoietic  stem  cell  (HSC)  niches  in  the  bone 
marrow  are  defined  as  the  cellular  and  molecular 
microenvironment that regulates HSC function [77]. This 
includes control of the balance between dormancy and 
active self-renewal division as well as progenitor output 
and  early  lineage  decisions.  Niche-derived  signals 
regulate  HSC  function  in  conjunction  with  cell 
autonomous mechanisms by forming HSC-niche units in 
which HSCs and niche cells exchange signals to generate 
a  stable,  but  dynamic  and  flexible,  entity  [78].  Most 
importantly, niches are not only essential for control of 
HSC  function  during  homeostasis,  but  niche-derived 
signals  are  also  critical  for  the  engagement  of  specific 
programs in response to stress. Bone marrow stress can 
be induced by bleeding or by cell loss induced by toxic 
substances,  including  chemotherapeutic  agents.  In 
addition, bacterial or viral infections and the associated 
inflammatory responses have a significant effect on HSCs 
Figure 6. Model in which molecular gradients along the apical-basal axis of the olfactory epithelium (OE) generate the neuronal stem cell 
niche. In the OE, differentiation proceeds in a basal-apical direction, with stem cells (yellow) and intermediate progenitors (shown in red and green) 
lying in a basal compartment, underneath the post-mitotic olfactory receptor neurons (shown in blue) to which they give rise. Note that localized 
expression, along with the interaction of growth differentiation factor (GDF)11 and activin with Fst (a high affinity antagonist of both proteins), 
create a niche within the OE in which the activity of factors that promote neurogenesis (for example, GDF7) is high, and that of factors that inhibit 
neurogenesis (for example, GDF11, activin) is low.
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issues have only started to be addressed experimentally. 
The goal of these repair processes in the bone is to rapidly 
restore homeostasis and have the highly precious HSCs 
return to a protected dormant state.
It is evident that a prerequisite for studying stem cell 
niches  is  detailed  knowledge  about  the  identity  and 
precise  localization  of  stem  cells  themselves.  HSCs, 
which mostly reside in the marrow of the long bones, 
hips  and  spine,  can  be  identified  and  isolated 
prospectively by multi-parameter flow cytometry (FACS) 
and  show  a  LinnegSca1hic-Kit+CD34-CD48-CD150hi 
phenotype. At the clonal level, they can reconstitute the 
entire  hematopoietic  system  of  lethally  irradiated  mice 
and are serially transplantable [80,81]. The population of 
HSCs  as  defined  above  contains  at  least  two  subsets. 
First,  active  HSCs,  which  ensure  the  continuous 
production  of  new  blood  cells  during  steady-state 
homeostasis,  and  second,  a  numerically  smaller  HSC 
population  harboring  superior  self-renewal  capacity. 
During  homeostasis  this  smaller  HSC  population  is 
retained  in  a  state  of  dormancy  (dormant  HSCs).  In 
response  to  stress,  niche  signals  activate  them  so  that 
they can be involved in the repair process after injury 
[81-84]. Both dormant and active HSCs are preferentially 
found  as  single  stem  cells  enriched  in  the  trabecular 
regions  of  long  bones.  However,  there  is  significant 
debate about the more detailed location of HSCs within 
the  marrow,  which  contains  both  the  endosteal  region 
close  to  the  bone  lining  osteoblasts  (OBs;  endosteal 
niche)  and  a  vascular  niche  located  around  small 
sinusoidal blood vessels associated with various stromal 
and  neuronal  elements.  While  FACS  allows  us  to 
combine at least eight parameters to identify HSCs ex 
vivo, advanced fluorescence microscope technology used 
to image HSC-niche units on bone sections is much more 
limited, making the localization of endogenous HSCs and 
their  niche  cells  in  tissue  sections  highly  challenging 
[78,85,86].
Nevertheless,  during  the  past  few  years  a  steadily 
increasing number of cell types have been proposed to 
regulate  HSC  function.  These  include  osteoblasts, 
osteoclasts,  macrophages  and  osteomacs,  CXCL12 
abundant  reticular  (CAR)  cells,  Nestin+  mesenchymal 
stem cells (MSCs), sympathetic nerves including Nestin+ 
Schwann  cells  and  finally  endothelial  cells  associated 
with  leptin  receptor-expressing  stromal  cells.  Osteo-
blastic cells were the first cell type identified as a HSC 
niche  component  (Figure  7).  Recent  reports  have 
suggested  that  specific  macrophages  named  osteomacs 
combine  with  OBs  to  regulate  HSC  engraftment  and 
granulocyte colony-stimulating factor-induced mobiliza  tion 
[78]. Most recently, additional cellular niche components 
were  revealed  by  the  use  of  several  knock-in  reporter 
mice in which green fluorescent protein was genetically 
inserted into genes anticipated to be expressed by niche 
cells. First, HSCs were found to be associated in part with 
CXCL12-expressing  CAR  cells  [87].  Some  of  the  CAR 
cells are part of the much smaller population of nestin-
expressing  stromal  cells  that  contain  functional  MSCs 
[88]. The latter express high levels of signaling molecules 
critical for HSCs, such as CXCL12, vascular cell adhesion 
molecule 1 (VCAM-1), Ang-1 and SCF. The activity of 
nestin+  MSCs  is  regulated,  at  least  in  part,  by  signals 
derived from macrophages and sympathetic nerves. To 
make matters even more complex, glial fibrillary acidic 
protein-expressing non-myelinating Schwann cells of the 
sympathetic nervous system have also been found within 
the nestin+ stromal population, although they are clearly 
distinct  from  MSCs  [89].  Most  importantly,  these 
Schwann cells can convert latent TGF-ß into active TGF-
ß, which in turn activates the TGF-ß type 2 receptor (RII) 
expressed by nearby HSCs and which is critical for HSC 
functionality.  The  immediate  relationship  between 
Figure 7. Model showing the various cell types comprising 
the bone marrow hematopoietic stem cell (HSC) niche. The 
dormant status of HSCs is maintained by transforming growth 
factor beta (TGF-ß) and thrombopoietin (TPO) produced by nestin+ 
non-myelinating Schwann cells and osteoblasts, respectively. Stem 
cell factor (SCF), which is essential for HSC maintenance, is mainly 
produced by leptin-receptor (LepR)-expressing mesenchymal 
stromal cells but also by nestin+ mesenchymal stem cells (MSCs) 
as well as sinusoidal endothelial cells (not shown). The sympathetic 
nervous system (SNS) negatively affects the activity of nestin+ MSCs. 
CXCL12 abundant reticular (CAR) cells produce the chemokine 
CXCL12, which facilitates lodging and engraftment as has been 
suggested for the high calcium concentration near the endosteal 
osteoblasts. The four stromal cell populations indicated in green may 
be somewhat overlapping and the relationship between these cell 
types remains to be elucidated. Osteomacs are specific macrophages 
that promote survival to osteoblasts and support nestin+ MSCs (not 
shown). Ang-1, angiopoietin-1.
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part  they  contribute  to  HSC  function  remain  to  be 
addressed.
Finally,  expression  of  SCF,  which  stimulates  the  Kit 
receptor on HSCs, and which is long known to activate a 
signaling  pathway  absolutely  required  for  HSC 
development,  maturation  and  function,  has  also  been 
studied  by  knock-in  reporter  mice  [90].  This  study 
suggests that SCF is moderately expressed by endothelial 
cells  of  the  marrow  sinusoids  and  at  higher  levels  by 
associated  leptin  receptor-expressing  perivascular 
stromal  (LEPS)  cells.  Genetic  elimination  of  SCF  from 
both cell types leads to loss of most HSCs, indicating the 
relevance of these cells for HSC function [90]. Since LEPS 
cells do not express nestin, they are distinct from MSCs 
and Schwann cells, but one cannot exclude the possibility 
that they overlap with CAR cells [91].
In  summary,  several  cell  types  cooperate  to  produce 
secreted  and  membrane-bound  signaling  molecules 
controlling  HSC  maintenance,  fate  and  function,  thus 
contributing to the formation of the complex HSC-niche 
unit.  These  signal/receptor  pairs  include:  SCF/KIT; 
CXCL12/CXCR4,  TGF-ß/TGFß  RII,  Ang-1/Tie2  and 
thrombopoietin/MPL and several others with more fine 
tuning effects on HSCs [77,89-93]. The last three have 
been suggested to promote dormancy or hibernation, a 
typical  feature  of  the  most  potent  HSCs  during 
homeostasis  [81,94].  Future  research  will  need  to 
decipher  the  three-dimensional  network  of  the  HSC-
niche unit, and to dissect the various extracellular signals 
and how these are translated into HSC fate and function. 
In  addition,  it  will  be  important  to  unravel  the 
architectural, cellular and molecular changes within the 
HSC-niche units in response to various stress situations, 
including  bacterial  and  viral  infections  as  well  as 
chemotherapy-induced  toxicity.  Not  only  will  a  better 
understanding  of  these  processes  in  mice  and  humans 
allow us to understand more clearly the many different 
facets of HSC biology during homeostasis and stress, but 
it may also provide direct clinical applications for many 
disease areas as well as for regenerative medicine.
Cancer stem cells and metastatic niches
Thordur Oskarsson
During  the  progression  of  cancer  and  formation  of 
metastasis,  tumor  cells  enter  the  circulation  and  are 
seeded to distant organs where they have to resist and 
overcome  a  non-permissive  environment  to  survive. 
These events can occur early and may already have taken 
place long before diagnosis of the primary tumor [95]. 
Increasing evidence suggests that, like normal stem cells, 
tumor-initiating cells, termed cancer stem cells, do not 
depend  solely  on  cell-intrinsic  events  but  instead  rely 
heavily on the right microenvironment – or niche – to 
maintain  activity  and  fitness  [96].  However,  unlike 
normal stem cell niches, which have evolved for millions 
of years, resulting in a fine-tuned crosstalk between stem 
cells and their environment, the cancer – or metastatic – 
niche  evolves  in  a  remarkably  short  time,  resulting  in 
more disordered interactions. The location of metastatic 
niches is also more loosely defined and can change as the 
disease  progresses.  Hypoxic  regions,  invasive  fronts, 
perivascular  sides  and  normal  stem  cell  niches  are  all 
possible  locations  where  metastatic  niches  can  form. 
Normal stem cell niches are influenced by the stem cells 
themselves, but the metastatic niche takes this to new 
heights. Recruitment of inflammatory cells, endothelial 
cells and myofibroblasts to the metastatic niche leads to a 
tremendously  complex  milieu  of  growth  factors, 
chemokines,  hormones,  enzymes  and  ECM  that  can 
promote  stem/progenitor  cell  traits  [97,98].  The  niche 
that  these  components  form  may  provide  cancer  stem 
cells with the necessary support to survive and grow into 
overt metastasis.
The qualities of metastatic niches are beginning to be 
resolved. Despite the somewhat chaotic nature of these 
niches, interesting parallels can be drawn between them 
and  normal  stem  cell  niches.  Certain  qualities  and 
molecular interactions within the cancer niche are indeed 
directly  adopted  from  normal  niches.  Many  of  these 
components  are  inducers  and  regulators  of  stem/
progenitor  pathways  like  the  Wnt,  Notch,  Hedgehog, 
phosphoinositide  3-kinase  (PI3K)  and  JAK-STAT 
pathways [99,100]. Moreover, evidence is accumulating 
on  the  importance  of  stem  cell  features  in  cancer 
progression  and  these  properties  are  associated  with 
poor  clinical  outcome  [99].  Intriguingly,  evidence 
supports not only a passive role of the niche maintaining 
already established stem/progenitor cell traits, but also 
that niche components can induce the cancer stem cell 
phenotype in already differentiated cancer cells. In colon 
carcinoma,  myofibroblasts  express  hepatocyte  growth 
factor (HGF), a ligand of c-Met receptor tyrosine kinase, 
leading  to  co-stimulation  and  enhancement  of  Wnt 
signaling  in  differentiated  cancer  cells  and  promoting 
their stem/progenitor properties [101]. This underscores 
the importance of the niche and may be a key feature of 
the cancer niche since the cancer stem cell phenotype 
may  be  a  rather  unstable  and  context-dependent  trait 
[102-104].
The initial events upon entry into distant organs can be 
critical  and  most  of  the  cancer  cells  die  soon  after 
extravasation  or  stay  dormant  indefinitely  [105,106]. 
Interesting  studies  have  proposed  that  signaling 
molecules from the primary tumor may cause changes in 
distant sites, thereby facilitating metastatic colonization. 
The environment that this generates has been termed a 
pre-metastatic  niche  [107].  Secretion  of  vascular 
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factor  (PlGF)  and  inflammatory  cytokines  leads  to 
mobilization of VEGF receptor 1 (VEGFR1)-expressing 
bone marrow-derived cells (BMDCs) and recruitment to 
the  lung  where  they  form  a  niche  that  enhances 
metastatic  outgrowth  (Figure  8a)  [107].  The  pre-
metastatic niche has also been shown to be enriched for 
molecules like fibronectin, matrix metalloproteinase 1/2, 
S100A8/9  and  lysyl  oxidase  (LOX),  leading  to  further 
recruitment  of  supportive  stromal  cells  and  to  ECM 
remodeling,  which  together  promote  the  growth  of 
cancer  cells  entering  the  niche  [108].  To  resist  the 
negative forces the cancer cells encounter at distant sites, 
they  take  advantage  of  the  molecular  interactions  and 
signaling normally active in niches. Interestingly, in some 
cases cancer cells can even seek out and ‘hijack’ already 
established  healthy  stem  cell  niches.  This  has  been 
demonstrated  in  prostate  malignancies,  where  cancer 
cells were shown to form micrometastases within HSC 
niches in the bone marrow and compete with HSCs for 
the niche interactions (Figure 8b) [109]. The chemokine 
CXCL12 and C-X-C chemokine receptor 4 (CXCR4), to 
which  it  binds,  form  an  axis  that  is  a  key  molecular 
interaction between HSCs and the bone niche [110], and 
is  also  engaged  in  bone  metastasis  of  prostate  cancer 
[111]. In addition, other cancers that metastasize to bone 
also  take  advantage  of  this  axis.  In  breast  cancer,  the 
CXCL12-CXCR4 axis is enhanced by high Src activity, 
reinforcing  PI3K  signaling  and  promoting  survival  of 
cancer  cells  lodged  in  the  bone  [112].  Whether  a 
competition similar to the one seen in the bone marrow 
niche also occurs in other stem cell niches remains to be 
seen. However, while the CXCL12-CXCR4 axis is a very 
important  mediator  of  bone  metastasis  in  cancers  like 
breast-,  prostate-  and  small  cell  lung  cancer,  this 
interaction also mediates metastasis to liver, brain and 
lungs [113]. Indeed, the chemokine CXCL12 is expressed 
by myofibroblasts and in hypoxic regions [114,115], both 
found  in  various  metastatic  sites  and  both  potential 
locations for a metastatic niche.
Important components of the metastatic niche can be 
expressed by the cancer cells themselves, thereby making 
cancer cells self-sufficient in this regard since they bring 
their own niche material to the distant site. The cancer 
cells that can produce components of a supportive niche 
on their own will gain a significant advantage upon their 
arrival  in  a  non-permissive  environment.  These 
components can be various growth factors, chemokines 
or  secreted  enzymes.  Moreover,  the  ECM  can  play  a 
significant  role  in  these  events.  It  is  increasingly 
appreciated  that  the  ECM  provides  more  than  a 
structural scaffold for cancer cells and is actively involved 
in modulating cellular signaling [116]. Indeed, the ECM 
protein tenascin C (TNC) expressed in normal stem cell 
Figure 8. Examples of metastatic niches during early colonization 
of distant organs. (a) Systemic changes induced by the primary breast 
tumor: mobilization of VEGFR1+ bone marrow-derived cells (BMDCs), 
recruitment to the lungs, extracellular matrix (ECM) remodeling and 
formation of a pre-metastatic niche [107,108]. The pre-metastatic 
niche promotes the colonization of breast cancer cells in the lungs. 
(b) Prostate cancer cells enter the osteoblastic niche, competing with 
hematopoietic stem cells (HSCs) for niche interactions in bone [109]. 
CXCL12 chemokine promotes colonization of prostate cancer cells 
in the bone niche via CXCR4 interaction [111]. (c) Breast cancer cells 
bringing their own niche material, tenascin C (TNC), to a distant site 
thereby promoting early colonization of the lungs [119]. (d) Activated 
myofibroblasts produce the metastatic niche components TNC and 
periostin (POSTN), resulting in enhanced metastatic outgrowth [119-
121]. VEGFR, vascular endothelial growth factor receptor.
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important role in metastatic breast cancer. Modulation of 
stem/progenitor signaling pathways as a result of TNC 
expression by the cancer cells was shown to be essential 
to ‘jump-start’ the growth of lung metastasis in breast 
cancer  (Figure  8c)  [119].  The  expression  of  TNC  is 
frequently found in circulating cancer cells isolated from 
the  pleural  effusion  of  patients  with  systemic  breast 
cancer,  suggesting  that  cancer  cell  autonomy  in  TNC 
production  may  have  a  role  in  the  broad  and  efficient 
spread of the disease [119]. Moreover, upon activation of 
the  microenvironment,  TNC  is  produced  by 
myofibroblasts  and  contributes  further  to  metastatic 
progression  [119,120].  In  addition  to  TNC, 
myofibroblasts  produce  periostin  (POSTN),  another 
ECM protein recently identified as a component of the 
metastatic niche (Figure 8d) [121]. Interestingly, the role 
of  POSTN  in  formation  of  lung  metastasis  shows  a 
striking  similarity  to  the  role  of  TNC,  tempting  us  to 
hypothesize  that  these  molecules  could  be  inter-
connected  or  collaborative  components  of  the  same 
supportive  system  [122].  TNC  and  POSTN  were 
demonstrated to regulate key signaling pathways involved 
in  the  maintenance  of  cancer  stem  cell  features  and 
activity  of  Wnt  and  Notch  pathways  [119,121]. 
Disseminated cancer stem cells engage these pathways to 
resist the inhospitable environment at distant sites.
Today, metastasis is essentially an incurable disease and 
there  is  a  desperate  need  for  new  measures  to  target 
metastatic  progression.  The  microenvironment  that 
metastatic cells engage and take advantage of to form a 
niche is a significant contributor to metastatic outgrowth. 
Moreover,  the  niche  may  possibly  also  contribute  to 
cancer stem cell resistance to therapeutic intervention. 
Future  studies  may  lead  to  identification  of  niche 
components  that  could  provide  new  targets  against 
metastatic progression. Targeting the niche and disrupting 
the nurturing effect it provides could present us with new 
means to prevent or even treat metastatic disease.
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